
@article{ref1,
title="Effectiveness of multisystemic therapy for adolescent antisocial behaviour: follow-up findings from the START trial",
journal="Lancet psychiatry",
year="2020",
author="Rogers, Jack C. and Broome, Matthew R.",
volume="7",
number="5",
pages="375-376",
abstract="<p> In The Lancet Psychiatry, Peter Fonagy and colleagues report 5-year follow-up findings from the Systemic Therapy for At Risk Teens (START) randomised controlled superiority trial of multisystemic therapy for young people exhibiting antisocial behaviour. 1 Antisocial behaviours are a key component of conduct disorder, a clinical syndrome often emerging during childhood or adolescence. 2 Conduct disorder is a heritable, stable disorder, presenting with a complex aetiology including contributions of both genetic and environmental risk factors and neurobiological differences. 3 ,  4 ,  5 Conduct disorder is predictive of lifelong mental health problems, low educational attainment, unemployment, criminality, and poor physical health. 2 Many young people with conduct disorder go on to develop antisocial personality disorders in adulthood, reflected in an exceptionally high familial, societal, and economic burden. 3 Providing effective interventions early is likely to lead to major benefits for patients, their families, and society. However, ongoing evaluation is essential when determining the long-term efficacy of these interventions and appraising the added value of such interventions over-and-above the cost of standard services. </p> <p>Language: en</p>",
language="en",
issn="2215-0374",
doi="10.1016/S2215-0366(20)30167-X",
url="http://dx.doi.org/10.1016/S2215-0366(20)30167-X"
}